ENAGenomicsVall d'hebron Institute de Recerca (VHIR)https://www.ebi.ac.uk/ena/browser/view/PRJNA788393In this study we aim to elucidate whether mutations found in plasma cfDNA could be confidently detected using next generation sequencing, and to evaluate if they are representative from driver mutations present in HCC tissue, providing the rationale to further develop this technology to monitor the dynamics of those mutations during patient follow upENAfalsecfDNA sequencing in early HCC2023-05-172023-01-08PRJNA788393